Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)
Bangladesh
· Delayed Price · Currency is BDT 752.70
-5.20 (-0.69%)
At close: Apr 28, 2026
Ambee Pharmaceuticals Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 27, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Market Capitalization | 1,806 | 1,960 | 1,829 | 1,318 | 1,260 | 985 | Upgrade
|
| Market Cap Growth | 2.17% | 7.12% | 38.81% | 4.57% | 27.92% | -14.60% | Upgrade
|
| Enterprise Value | 2,363 | 2,445 | 2,240 | 1,629 | 1,521 | 1,202 | Upgrade
|
| Last Close Price | 752.70 | 815.42 | 760.13 | 546.57 | 521.71 | 407.85 | Upgrade
|
| PE Ratio | 273.53 | 369.08 | 188.91 | 144.98 | 156.37 | - | Upgrade
|
| PS Ratio | 9.84 | 8.50 | 8.34 | 6.65 | 6.96 | 9.95 | Upgrade
|
| PB Ratio | 52.52 | 60.61 | 62.17 | 56.46 | 23.92 | 21.97 | Upgrade
|
| P/TBV Ratio | 52.52 | 60.61 | 62.17 | 56.46 | 23.92 | 21.97 | Upgrade
|
| P/OCF Ratio | 89.23 | 90.16 | - | - | - | - | Upgrade
|
| EV/Sales Ratio | 12.87 | 10.61 | 10.22 | 8.22 | 8.40 | 12.14 | Upgrade
|
| EV/EBITDA Ratio | 185.86 | 196.29 | 122.73 | 80.79 | 77.41 | - | Upgrade
|
| EV/EBIT Ratio | - | 330.94 | 180.50 | 123.64 | 102.35 | - | Upgrade
|
| Debt / Equity Ratio | 19.20 | 19.76 | 0.03 | 16.82 | 6.55 | 5.35 | Upgrade
|
| Debt / EBITDA Ratio | 51.93 | 49.53 | 0.05 | 18.95 | 16.49 | - | Upgrade
|
| Net Debt / Equity Ratio | 16.19 | 15.66 | -1.08 | 15.59 | 6.22 | 5.01 | Upgrade
|
| Net Debt / EBITDA Ratio | 45.38 | 40.65 | -1.75 | 18.05 | 16.70 | -134.45 | Upgrade
|
| Net Debt / FCF Ratio | 106.05 | -245.76 | 0.47 | -10.30 | -4.39 | -41.23 | Upgrade
|
| Asset Turnover | 0.25 | 0.35 | 0.40 | 0.39 | 0.39 | 0.23 | Upgrade
|
| Inventory Turnover | 0.39 | 0.55 | 0.49 | 0.49 | 0.54 | 0.40 | Upgrade
|
| Quick Ratio | 0.44 | 0.47 | 0.38 | 0.34 | 0.29 | 0.29 | Upgrade
|
| Current Ratio | 0.84 | 0.83 | 0.91 | 0.88 | 0.92 | 0.87 | Upgrade
|
| Return on Equity (ROE) | 20.45% | 17.19% | 36.70% | 23.91% | 16.53% | -25.34% | Upgrade
|
| Return on Assets (ROA) | 0.44% | 0.70% | 1.41% | 1.62% | 2.01% | -1.07% | Upgrade
|
| Return on Invested Capital (ROIC) | 0.67% | 2.00% | 5.28% | 2.92% | 3.60% | -2.68% | Upgrade
|
| Return on Capital Employed (ROCE) | 13.80% | 20.30% | 36.30% | 44.70% | 24.80% | -13.70% | Upgrade
|
| Earnings Yield | 0.37% | 0.27% | 0.53% | 0.69% | 0.64% | -1.32% | Upgrade
|
| FCF Yield | 0.29% | -0.10% | -3.72% | -2.68% | -5.93% | -0.55% | Upgrade
|
| Dividend Yield | 0.13% | 0.12% | 0.13% | 0.27% | 0.19% | - | Upgrade
|
| Payout Ratio | 32.37% | 44.23% | 34.91% | 11.00% | 18.61% | - | Upgrade
|
| Total Shareholder Return | 0.13% | 0.12% | 0.13% | 0.27% | 0.19% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.